Research further shows a significant association between patients with psoriasis and an increased incidence of obstructive ...

UCB SA has a promising drug, Bimzelx, despite temporary EBITDA decline and potential regulatory hurdles ahead. Learn more ...

Biosimilars are safe, effective, and well-tolerated for psoriasis treatment, providing significant cost savings for the ...

Though psoriasis affects people of all skin tones, that diversity isn’t always represented in portrayals of the condition in ...

Despite uncertainty around who will sit in The White House in January and what ramifications they may bring, the industry’s ...

At 52 weeks of follow-up, more patients on Eli Lilly’s monoclonal antibody Omvoh demonstrated histologic response, suggesting ...

Imuldosa is used for the treatment of patients with autoimmune diseases such as plaque psoriasis, psoriatic arthritis, ...

There is no simple solution to tackling health inequity, but we’re confident that infusing health equity principles across ...

She is board certified in general and child/adolescent psychiatry and specializes in the treatment of conditions such as ADHD, autism, anxiety, depression, bipolar disorder, and PTSD. Medications ...

Seeing a skin doctor isn’t just about checking for moles or getting a cream for acne or wrinkles. Dermatologists may see ...

News Obese Children Are More Likely to Develop Skin Conditions Related to the Immune System. Childhood obesity can contribute to the development of common immune-mediated skin dis ...

Accord BioPharma has received FDA approval for IMULDOSA, a biosimilar to STELARA, for treating chronic inflammatory conditions like psoriasis and Crohn's disease. Scheduled for a 2025 launch, it aims ...